Current Pharmaceutical Biotechnology
6 Citations•2021•
Çisel Yazgan, H. Ertürk, Ayşenaz Taşkın
journal unavailable
Extracellular Vesicle (EV)-based therapy has been identified as a leading alternative approach in several disease models and has been documented for its strong neuro-regenerative capacity.
Abstract
DOI: 10.2174/1567202618666211012162111 Abstract: Background: Extracellular Vesicle (EV)-based therapy has been identified as a leading alternative approach in several disease models. EV derived from the Olfactory Ensheathing Cell (OEC) has been documented for its strong neuro-regenerative capacity. However, no information on its cargo that may contribute to its therapeutic effect has been available.